- In September 2024, Cordlife Group resumed its cord blood banking activities in Singapore with an enhanced processing and storage facility, featuring improved operational protocols and an advanced laboratory monitoring system
- In July 2024, NMDP Biosciences and the Cord Blood Bank Alliance (CBBA) announced the availability of pre-identified cord blood units optimized for manufacturing cord-derived cell therapies, particularly natural killer (NK) cell therapies
- In May 2024, The Department of Health (DOH) and M42 collaborated to launch the Abu Dhabi Biobank, the region's largest hybrid cord blood bank, aiming to reduce treatment waiting times and improve therapeutic access for patients
- In February 2024, Americord released cord blood stem cells to a client’s grandmother in India for the treatment of motor neuron disease, demonstrating the expanding therapeutic applications of stored cord blood
- In November 2024, Sidra Medicine, part of Qatar Foundation, launched Qatar’s first local cord blood banking service, offering families the opportunity to preserve their newborns’ stem cells for potential future medical needs
